Most Medicare beneficiaries intend to review their Medicare options during annual enrollment period
According to a recently released survey by eHealth, Inc. while about 78 percent of Medicare beneficiaries are happy with their
Read More
Part D/Prescription Drugs
Medicare beneficiaries who are seriously ill struggle with financial burdens as a result of high out-of-pocket medical costs
In a recent survey conducted by Harvard University found that 30 percent of Medicare beneficiaries who are seriously ill reported
Read MoreVoters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?
(By Emmarie Huetteman for Kaiser Health News) House Democrats are poised to pass sweeping legislation to lower drug prices using
Read MoreBe sure to do your research before switching up your Medicare coverage.
During Medicare open enrollment period, which started October 15 and runs until December 7, Medicare recipients have an opportunity to
Read MoreWhat is quality-adjusted life year?
What is a quality-adjusted life year and why is this relevant to medicine? Quality-adjusted life year or QALY represents one
Read MoreWays to cut your Medicare costs
Medicare, the government’s health insurance program for seniors, helps with health care costs, but it’s not free. Most beneficiaries pay
Read MoreYou need to closely at your Medicare Advantage plan
In a recent report from eHealth found that 45,000 users of its site with Medicare Advantage Part D plans could
Read MoreMake your next Medicare premium payment online
(Source – www.medicare.gov/blog) If you get a bill from Medicare for your premiums, you may now be able to pay
Read MoreSeema Verma: CMS’s ‘expanded pathway’ for new antibiotics can help fight antimicrobial resistance
(By Seema Verma, administrator of the Centers for Medicare and Medicaid Services for STAT) Americans are under siege by drug-resistant
Read MoreA new Alzheimer’s therapy is approved in China, delivering a surprise for the field but also questions
(By Andrew Joseph for STAT) Chinese regulators have granted conditional approval to an Alzheimer’s drug that is derived from seaweed,
Read More